IBER.WS

Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

IBER.WS was delisted on the 15th of February, 2023.

Back to rankings

20 hedge funds and large institutions have $3.27M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.21M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.45M
2
+$209K
3
+$207K
4
LA
Linden Advisors
New York
+$169K
5
SC
Sculptor Capital
New York
+$160K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.45M
2
$209K
3
$207K
4
$169K
5
$160K
6
$152K
7
$152K
8
$133K
9
$123K
10
$114K
11
$96K
12
$76K
13
$64K
14
$57K
15
$31K
16
$29K
17
$19K
18
$13K
19
$10K
20
$10K